NIP
ONCE

Nicholas Investment Partners’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Nicholas Investment Partners’s Portfolio ONCE Stock Details ONCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-37,540
Closed -$2.26M – 338
2015
Q2 		$2.26M Buy
37,540
+20,856
+125% +$1.38M 0.14% 248
2015
Q1 		$1.29M Buy
+16,684
New +$961K 0.08% 282

Other funds holding ONCE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
BCPEM
Bain Capital Public Equity Management Boston, Massachusetts $1.05B AUM 25.71% 1-Year Est. Return

Nicholas Investment Partners's ONCE Position: Q3 2015 in Review

Nicholas Investment Partners sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q3 2015, closing a stake of 37,540 shares — an estimated $2.26M sold.

Nicholas Investment Partners first reported a position in ONCE in Q1 2015 and held it in 2 quarters. The position peaked at $2.26M in Q2 2015. 90 funds tracked by Wall St. Rank hold ONCE as of Q3 2015.

  • Nicholas Investment Partners reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q3 2015 after selling out during the quarter.
  • Nicholas Investment Partners sold 37,540 Spark Therapeutics, Inc. Common Stock shares in Q3 2015, an estimated $2.26M.
  • Nicholas Investment Partners first reported a position in Spark Therapeutics, Inc. Common Stock in Q1 2015 and held it in 2 quarters.
  • Nicholas Investment Partners's Spark Therapeutics, Inc. Common Stock position peaked at $2.26M in Q2 2015.
  • 90 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q3 2015.

Based on Nicholas Investment Partners's 13F filing for Q3 2015, filed 17 Nov 2015.